Company profile for Medeor Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our company was founded with a life-changing mission in mind: to enable the immune system in one human to benefit another. Our goals include a world in which organ transplant patients are able to minimize or eliminate the need for immunosuppressant drugs and their associated toxicities, while living full and healthy lives. Furthermore, we intend to address unmet needs across numerous hematologic and rare diseases where chimeri...
Our company was founded with a life-changing mission in mind: to enable the immune system in one human to benefit another. Our goals include a world in which organ transplant patients are able to minimize or eliminate the need for immunosuppressant drugs and their associated toxicities, while living full and healthy lives. Furthermore, we intend to address unmet needs across numerous hematologic and rare diseases where chimerism would provide significant clinical benefit. What began more than 20 years ago at Stanford University has evolved into a promising biomedical platform that has helped to enable pivotal immunotherapy clinical trials wi

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
611 Gateway Blvd. Suite 120 South San Francisco, CA 94080
Telephone
Telephone
+1.650.627.4531
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/medeors-cell-therapy-boosts-immune-tolerance-in-registrational-trial-of-donor-kidney-recipients/

Ayisha Sharma ENDPTS
02 Nov 2023
Cell therapy allows kidney recipients to cut immunosuppressants
Cell therapy allows kidney recipients to cut immunosuppressants

02 Nov 2023

// Annalee Armstrong FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/medeor-cell-therapy-helps-kidney-transplant-patients-taper-immunosuppressant-meds

Annalee Armstrong FIERCE BIOTECH
02 Nov 2023

https://www.businesswire.com/news/home/20210520005143/en/Medeor-Therapeutics-to-Provide-Interim-Results-of-Phase-3-Mercury-Study-of-MDR-101-Cell-Therapy-in-Living-Donor-Kidney-Transplants-During-Rapid-Fire-Oral-Presentation-at-ATC-Virtual-Congress

BUSINESSWIRE
20 May 2021

https://www.businesswire.com/news/home/20210520005143/en/Medeor-Therapeutics-to-Provide-Interim-Results-of-Phase-3-Mercury-Study-of-MDR-101-Cell-Therapy-in-Living-Donor-Kidney-Transplants-During-Rapid-Fire-Oral-Presentation-at-ATC-Virtual-Congress

BUSINESSWIRE
20 May 2021

https://www.businesswire.com/news/home/20210512005064/en

BUSINESSWIRE
12 May 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty